DNA X, Inc. (SONM) shareholders
SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
$2.17−0.21 (-8.82%)
Close on Nov 13, 2026Market cap $3.23MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
5.9%
0M of 1M shares
Institutional holders
9
1 new, 1 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Jeffrey Wang Joint filing with Orbic North America, LLC. (19.04%), Ashima Narula (19.04%) and 2 more | 1,972,124 | 19.04% | 13D (active) amendment | Jun 26, 2025 |
| Orbic North America, LLC. Joint filing with Ashima Narula (30.70%), Parveen Narula (30.70%) and 2 more | 1,947,345 | 30.70% | 13D (active) amendment | Apr 16, 2025 |
| Ashima Narula Joint filing with Orbic North America, LLC. (30.70%), Parveen Narula (30.70%) and 2 more | 1,947,345 | 30.70% | 13D (active) amendment | Apr 24, 2025 |
| Parveen Narula Joint filing with Orbic North America, LLC. (30.70%), Ashima Narula (30.70%) and 2 more | 1,947,345 | 30.70% | 13D (active) amendment | Apr 10, 2025 |
| Yaron Naymark Joint filing with 1 Main Capital Management, LLC (8.20%), 1 Main Capital Partners, L.P. (6.80%) and 1 more | 1,516,842 | 8.20% | 13G (passive) amendment | Sep 30, 2025 |
| Laurence W. Lytton | 866,916 | 17.80% | 13G (passive) amendment | Feb 20, 2025 |
| Jiang Liu | 497,943 | 9.90% | 13G (passive) | Sep 12, 2024 |
| Hao (Peter) Liu | 357,254 | 7.16% | 13D (active) | Jul 14, 2023 |
| Scott Walker Joint filing with DNA Holdings Venture Inc. (19.90%), Brock Pierce (19.90%) | 223,201 | 19.90% | 13D (active) | Dec 15, 2025 |
| Lytton Laurence W | 100,521 | 6.80% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SONM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| C2C Wealth Management, LLC | 35,500 | 2.39% | $182.83K | +15,500 | 0.14% |
| BlackRock, Inc. | 14,006 | 0.94% | $72.13K | – | 0.00% |
| Citadel Advisors LLC | 12,740 | 0.86% | $65.10K | New | 0.00% |
| Geode Capital Management, LLC | 12,584 | 0.85% | $64.30K | −2,218 | 0.00% |
| Vanguard Capital Management LLC | 5,901 | 0.40% | $30.15K | +1,009 | 0.00% |
| Vanguard Fiduciary Trust Co | 4,496 | 0.30% | $22.98K | – | 0.00% |
| UBS Group AG | 2,304 | 0.15% | $11.87K | −33,915 | 0.00% |
| Tower Research Capital LLC (TRC) | 642 | 0.04% | $3.31K | −19 | 0.00% |
| SBI Securities Co., Ltd. | 214 | 0.01% | $1.10K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 9 | 0M | 5.9% | 1 / 2 | 3 / 1 | 0M | 0M |
| Q1 2026 | 9 | 0M | 6.4% | 5 / 1 | 0 / 4 | 0M | 0M |
| Q4 2025 | 8 | 0M | 5.7% | 2 / 2 | 3 / 8 | 0M | 0M |
| Q3 2025 | 14 | 0M | 1.9% | 4 / 2 | 3 / 10 | 0M | 0M |
| Q2 2025 | 20 | 0M | 0.9% | 11 / 6 | 0 / 3 | 0M | 0M |
| Q1 2025 | 12 | 0M | 0.5% | 2 / 4 | 1 / 1 | 0M | 0M |
| Q4 2024 | 11 | 0M | 0.3% | 2 / 2 | 0 / 2 | 0M | 0M |
| Q3 2024 | 11 | 0M | 0.4% | 5 / 3 | 0 / 10 | 0M | 0M |
| Q2 2024 | 17 | 0M | 0.4% | 4 / 3 | 3 / 7 | 0M | 0M |
| Q1 2024 | 20 | 0M | 0.5% | 4 / 3 | 3 / 2 | 0M | 0M |
| Q4 2023 | 18 | 0M | 0.5% | 3 / 3 | 4 / 2 | 0M | 0M |
| Q3 2023 | 17 | 0M | 0.5% | 6 / 4 | 3 / 2 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
5 funds held SONM in Q2 2026, 33% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SONM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 8,027 | 0.54% | $35.00K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 5,901 | 0.40% | $30.15K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 2,951 | 0.20% | $12.87K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 1,057 | 0.07% | $4.61K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 184 | 0.01% | $802 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael C. Mulica | Acting CEO, Director | 54,071 | 3.63% | Feb 10, 2026 |
| Hao Peter Liu | Chief Executive Officer, Director | 269,388 | 18.10% | Feb 10, 2025 |
| Clayton Crolius | Chief Financial Officer | 36,719 | 2.47% | Feb 10, 2026 |
| Charles Becher | See Remarks | 62,668 | 4.21% | Apr 25, 2025 |
| George Thangadurai | Director | 723 | 0.05% | Oct 15, 2025 |
| Jack Steenstra | Director | 49,139 | 3.30% | Apr 25, 2025 |
| Jeffrey Wang | Director | 1,967,647 | 132.21% | Apr 25, 2025 |
| James S. Cassano | Director | 49,126 | 3.30% | Apr 25, 2025 |
| Holdings Venture Inc. DNA | 10% owner | 223,201 | 15.00% | Feb 20, 2026 |
| Laurence W. Lytton | 10% owner | 800,000 | 53.75% | Jul 7, 2025 |
| Ashima Narula | 10% owner | 1,947,345 | 130.85% | Mar 21, 2025 |
| North America LLC Orbic | 10% owner | – | – | Mar 21, 2025 |
| Parveen Narula | 10% owner | – | – | Mar 21, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael C. Mulica Acting CEO, Director | Feb 9, 2026 | Award | +50,000 | – | – | 54,071 |
| Clayton Crolius Chief Financial Officer | Feb 9, 2026 | Award | +35,000 | – | – | 36,719 |
| Laurence W. Lytton 10% owner | Jun 30, 2025 | Sale | −400,514 | $1.39 | $556.71K | 0 |
| Laurence W. Lytton 10% owner | Jun 26, 2025 | Sale | −466,402 | $1.50 | $699.60K | 400,514 |
| Clayton Crolius Chief Financial Officer | Apr 23, 2025 | Sale | −11,634 | $1.45 | $16.87K | 30,958 |
| Jack Steenstra Director | Apr 23, 2025 | Sale | −23,381 | $1.45 | $33.90K | 49,139 |
| Charles Becher See Remarks | Apr 23, 2025 | Sale | −31,326 | $1.45 | $45.42K | 62,668 |
| Jeffrey Wang Director | Apr 23, 2025 | Sale | −4,478 | $1.45 | $6.49K | 21,301 |
| Michael C. Mulica Director | Apr 23, 2025 | Sale | −27,818 | $1.45 | $40.34K | 73,292 |
| James S. Cassano Director | Apr 23, 2025 | Sale | −23,381 | $1.45 | $33.90K | 49,126 |
| Jack Steenstra Director | Mar 31, 2025 | Award | +46,728 | – | – | 72,520 |
| James S. Cassano Director | Mar 31, 2025 | Award | +46,728 | – | – | 72,507 |
| Michael C. Mulica Director | Mar 31, 2025 | Award | +46,728 | – | – | 101,110 |
| Clayton Crolius Chief Financial Officer | Feb 6, 2025 | Award | +33,922 | – | – | 42,592 |
| Charles Becher See Remarks | Feb 6, 2025 | Award | +70,671 | – | – | 93,994 |
| Hao Peter Liu Chief Executive Officer, Director | Feb 6, 2025 | Award | +63,604 | – | – | 269,388 |
| Michael C. Mulica Director | Nov 13, 2024 | Sale | −2,559 | $3.28 | $8.39K | 54,382 |
| Michael C. Mulica Director | Nov 12, 2024 | Award | +14,124 | – | – | 56,941 |
| Jack Steenstra Director | Jul 19, 2024 | Sale | −1,623 | $3.67 | $5.96K | 25,792 |
| James S. Cassano Director | Jul 19, 2024 | Sale | −1,623 | $3.68 | $5.97K | 25,779 |
| Jeffrey Wang Director, 10% owner | Jul 19, 2024 | Sale | −1,623 | $3.67 | $5.96K | 25,779 |
| Michael C. Mulica Director | Jun 21, 2024 | Sale | −36,016 | $0.69 | $24.85K | 428,156 |
| James S. Cassano Director | Jun 21, 2024 | Sale | −36,015 | $0.69 | $24.85K | 274,012 |
| Jack Steenstra Director | Jun 21, 2024 | Sale | −35,882 | $0.69 | $24.76K | 274,145 |
| Jeffrey Wang Director, 10% owner | Jun 21, 2024 | Sale | −36,016 | $0.69 | $24.85K | 274,011 |
| Michael C. Mulica Director | Jun 20, 2024 | Award | +78,947 | – | – | 464,172 |
| James S. Cassano Director | Jun 20, 2024 | Award | +78,947 | – | – | 310,027 |
| Jack Steenstra Director | Jun 20, 2024 | Award | +78,947 | – | – | 310,027 |
| Jeffrey Wang Director, 10% owner | Jun 20, 2024 | Award | +78,947 | – | – | 310,027 |
| Michael C. Mulica Director | Jan 9, 2024 | Award | +66,675 | – | – | 385,225 |
| Charles Becher See Remarks | Dec 26, 2023 | Option exercise | +125,000 | $0.42 | $52.50K | 233,227 |
| Michael C. Mulica Director | Sep 28, 2023 | Award | +89,525 | – | – | 318,550 |
| Jeffrey Wang Director, 10% owner | Sep 28, 2023 | Award | +89,525 | – | – | 231,080 |
| James S. Cassano Director | Sep 28, 2023 | Award | +89,525 | – | – | 231,080 |
| Jack Steenstra Director | Sep 28, 2023 | Award | +89,525 | – | – | 231,080 |
| Clayton Crolius Chief Financial Officer | Sep 15, 2023 | Buy | +86,700 | $0.68 | $58.96K | 86,700 |
| Hao Peter Liu Chief Executive Officer, Director | Aug 23, 2023 | Option exercise | +1,000,000 | $0.42 | $420.00K | 2,057,831 |
| Alan B. Howe Director | Mar 24, 2023 | Buy | +1,818 | $0.60 | $1.09K | 176,403 |
| James S. Cassano Director | Nov 18, 2022 | Award | +47,732 | – | – | 141,555 |
| Alan B. Howe Director | Nov 18, 2022 | Award | +47,732 | – | – | 174,585 |
| Michael C. Mulica Director | Nov 18, 2022 | Award | +47,732 | – | – | 229,025 |
| Jeffrey Wang Director, 10% owner | Nov 18, 2022 | Award | +47,732 | – | – | 141,555 |
| Jose Carlos Principe Director | Nov 18, 2022 | Award | +47,732 | – | – | 149,426 |
| Jack Steenstra Director | Nov 18, 2022 | Award | +47,732 | – | – | 141,555 |
| AJP Holding Company, LLC 10% owner | Aug 8, 2022 | Buy | +5,534,881 | $0.84 | $4.65M | 19,463,452 |
| Jeffrey Wang Director, 10% owner | Aug 8, 2022 | Buy | +5,534,881 | $0.84 | $4.65M | 19,463,452 |
| James S. Cassano Director | Aug 5, 2022 | Award | +93,823 | – | – | 93,823 |
| Jack Steenstra Director | Aug 5, 2022 | Award | +93,823 | – | – | 93,823 |
| Jeffrey Wang Director, 10% owner | Aug 5, 2022 | Award | +93,823 | – | – | 93,823 |
| Jose Carlos Principe Director | Aug 5, 2022 | Award | +101,694 | – | – | 101,694 |
| Jose Carlos Principe Director | Aug 5, 2022 | Award | +85,714 | – | – | 85,714 |
| Michael C. Mulica Director | Aug 5, 2022 | Award | +85,714 | – | – | 181,293 |
| Alan B. Howe Director | Aug 5, 2022 | Award | +85,714 | – | – | 126,853 |
| James S. Cassano Director | Aug 5, 2022 | Award | +85,714 | – | – | 85,714 |
| Jack Steenstra Director | Aug 5, 2022 | Award | +85,714 | – | – | 85,714 |
| Jeffrey Wang Director, 10% owner | Aug 5, 2022 | Award | +85,714 | – | – | 85,714 |
| Robert L. Tirva Former President, CFO & COO | Jul 15, 2022 | Sale | −729 | $0.76 | $554 | 314,619 |
| Robert L. Tirva Former President, CFO & COO | Jul 13, 2022 | Sale | −9,176 | $0.54 | $4.96K | 315,348 |
| Hao Peter Liu Chief Executive Officer, Director | Jul 13, 2022 | Buy | +952,381 | $0.84 | $800.00K | 1,059,867 |
| Jeffrey Wang Director, 10% owner | Jul 13, 2022 | Buy | +13,928,571 | $0.84 | $11.70M | 13,928,571 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
0.66%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-9.1%
From 0M shares
Short volume, 20 days
26.9%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of DNA X's stock actually held short. Settlement fails (shares not delivered on time) peaked at 481 shares on Sep 18, 2026 over the last 90 days.
See a number that looks wrong?